COMMONWEALTH EQUITY SERVICES, LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 312272
WALTHAM, MA
Position in CADL
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$467,435
+$2,181 QoQ
Shares Held
95,395
+15.8% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. CADL ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,972 | $24,547,196 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,385 | $12,659,706 | |
| 3 | EXEL |
Exelixis, Inc.
|
173,762 | $7,452,652 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
180,285 | $5,989,067 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
80,892 | $5,674,573 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
78,488 | $3,733,674 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,577 | $3,499,611 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,076 | $3,453,265 |
All Filings in CADL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $467,435 | 95,395 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $465,254 | 82,346 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $419,327 | 82,221 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $412,901 | 81,601 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $367,656 | 65,072 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $356,730 | 41,098 | Shares | Sole | 2025-02-10 | |
| 2024-03-31 | $22,407 | 14,182 | Shares | Sole | 2024-04-29 | |
| No filing history on record for this holder in this stock. | ||||||